
ResistanceBio YC 申请
ResistanceBio 在 Winter 2019 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是:公司做什么、谁创立了它,以及其 YC 申请,按照真实 YC 表格逐题重建。
- YC 批次
- Winter 2019
- 行业
- HealthcareTherapeutics
- 团队规模
- 15
- 状态
- Inactive
- 已发布
- 2018
创始人
Nicholas GoldnerCEO/Founder
Christopher BulowFounder
ResistanceBio 的 YC 申请,重建版
Y Combinator 申请
ResistanceBio,Winter 2019 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
ResistanceBio
We solve drug resistance for cancer
We build AI-powered drug discovery tools that identify therapies to overcome resistance in cancer treatment. Our platform analyzes biological data to predict how tumors develop resistance and suggests drug combinations to counteract that.
We live in Menlo Park, CA and Overland, MO currently. After YC, the company would be based in Menlo Park, CA to tap into the startup ecosystem and investor network.
We chose Menlo Park post-YC to be close to biotech innovation hubs and investors. Overland is where some of our operational and technical team is currently located, but the move aligns with strategic growth.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开,紧邻每个其他 YC 批次。
常见问题解答
这是 ResistanceBio 的真实 YC 申请吗?
不是。Y Combinator 对提交的申请保密。这是重建版:使用 ResistanceBio 的公开数据(发布笔记、创始人背景、产品描述)回答真实的 YC 表格问题。它展示了像 ResistanceBio 这样的公司会如何向 YC 自我介绍,而不是他们提交的文本。
ResistanceBio 是哪个 YC 批次的?
ResistanceBio 是 Y Combinator Winter 2019 批次的成员。
谁创立了 ResistanceBio?
ResistanceBio 由 Nicholas Goldner, Christopher Bulow 创立。
ResistanceBio 做什么?
We solve drug resistance for cancer
如何阅读完整的重建申请?
创建免费的 Round Funded 账户。YC Insights 中包含 ResistanceBio 的完整 26 个问题的版本,以及其他所有 YC 批次的公司信息。